India is participating in the NeoSep1 clinical trial, which aims to improve treatment for drug-resistant newborn sepsis using ...

Flosonics Medical received the Paul and Debra Walker Award, part of the Sepsis Research and Innovation Challenge at the Unite for Sepsis Symposium presented by Sepsis Alliance in Washington, D.C. on ...

Jipmer becomes the first Indian center to enroll an infant in the NeoSep1 trial, targeting neonatal sepsis and antimicrobial resistance.

India has enrolled its first newborn in the global NeoSep1 trial at JIPMER, Puducherry. The study will test antibiotic ...

The Global Antibiotic Research and Development Partnership (GARDP) said yesterday that an international clinical trial ...

The Integrated Assessment Tool assesses aged care needs to determine eligibility for government-supported aged care services.

Will AI replace healthcare jobs? Not exactly. Learn which roles face the greatest disruption, which remain resilient, and how ...

TikTok creates purchase urgency faster than any review process can keep up with — and the only honest way to find out whether ...

The NeoSep1 trial is expected to enroll 3,000 newborns across Asia and Africa by the end of 2028. ​Along with India, newborns ...

Several Twin Cities beaches are temporarily closed due to Escherichia coli, also known as E. coli, according to city and ...

FSSAI has issued notices to six energy drink brands, including Red Bull and Monster, over alleged misbranding. Doctors ...

The first step to understanding AI’s real potential is turning down the volume on the people who are selling it most loudly.